Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Prediction of response to anti...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition.

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition.

Bibliographic Details
Main Authors: Alessandro eOttaiano, Maurizio eCapuozzo, Guglielmo eNasti, Piera eMaiolino, Valentina eDe Angelis, Stefania eScala, Vincenzo Rosario eIaffaioli
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-01-01
Series:Frontiers in Immunology
Subjects:
EGFR
colorectal cancer
ADCC
cetuximab
KRAS
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00409/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00409/full

Similar Items

  • Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
    by: Cavazzoni Andrea, et al.
    Published: (2012-12-01)
  • A view on EGFR-targeted therapies from the oncogene-addiction perspective
    by: Rolando ePerez, et al.
    Published: (2013-04-01)
  • Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
    by: Jacqueline V Aredo, et al.
    Published: (2022-01-01)
  • EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
    by: Balakarthikeyan Janani, et al.
    Published: (2022-03-01)
  • Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody
    by: Yu-Wei Lin, et al.
    Published: (2022-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs